Evoke Pharma Inc 's (EVOK) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Evoke Pharma Inc   (NASDAQ: EVOK)
 



  Evoke Pharma Inc Outlook

On May 14 2024 the Evoke Pharma Inc provided following guidance

Evoke Pharma Inc. has released its first quarter financial results for 2024, showing a significant 114% year-over-year increase in net product sales. Additionally, the company experienced a 70% increase in prescriber growth during the first quarter of 2024 compared to the previous quarter. These growing sales metrics are a positive indicator of the company's performance and have reaffirmed their guidance of $14 million in net revenue for the year 2024. This strong start to the year showcases Evoke Pharma's potential for continued success and growth in the pharmaceutical industry.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.